about
Leveraging the cortical cholinergic system to enhance attentionNeuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognitionAttention-modulating effects of cognitive enhancersCholinergic modulation of the medial prefrontal cortex: the role of nicotinic receptors in attention and regulation of neuronal activityA mouse model of the 15q13.3 microdeletion syndrome shows prefrontal neurophysiological dysfunctions and attentional impairment.Strain dependency of the effects of nicotine and mecamylamine in a rat model of attentionNegative affective states and cognitive impairments in nicotine dependenceMuscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophreniaThe enhancement of contextual fear conditioning by ABT-418.Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men.Galantamine facilitates acquisition of a trace-conditioned eyeblink response in healthy, young rabbits.Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task.Dietary and genetic manipulations of folate metabolism differentially affect neocortical functions in mice.Detrimental effects of acute nicotine on the response-withholding performance of spontaneously hypertensive and Wistar Kyoto ratsAcute effects of mecamylamine and varenicline on cognitive performance in non-smokers with and without schizophrenia.Prefrontal beta2 subunit-containing and alpha7 nicotinic acetylcholine receptors differentially control glutamatergic and cholinergic signalingExtinction with varenicline and nornicotine, but not ABT-418, weakens conditioned responding evoked by the interoceptive stimulus effects of nicotine.Modes and models of forebrain cholinergic neuromodulation of cognition.Drug discrimination in methamphetamine-trained rats: effects of cholinergic nicotinic compounds.Role of neuronal nicotinic acetylcholine receptors (nAChRs) on learning and memory in zebrafish.SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia.Pharmacological enhancement of memory and executive functioning in laboratory animals.Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits.Task demands dissociate the effects of muscarinic M1 receptor blockade and protein kinase C inhibition on attentional performance in rats.Effects of nicotine and mecamylamine on cognition in rhesus monkeys.Estimating binding affinities of the nicotinic receptor for low-efficacy ligands using mixtures of agonists and two-dimensional concentration-response relationshipsEffects of nicotinic acetylcholine receptor agonists on cognition in rhesus monkeys with a chronic cocaine self-administration history.Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function.Impaired cognition and attention in adults: pharmacological management strategies.A test of the cognitive self-medication hypothesis of tobacco smoking in schizophrenia.Nicotine enhances visuospatial attention by deactivating areas of the resting brain default network.A randomized, double-blind, placebo-controlled crossover study of α4β 2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder.Developmental Ethanol Exposure Leads to Long-Term Deficits in Attention and Its Underlying Prefrontal Circuitry.nAChR agonist-induced cognition enhancement: integration of cognitive and neuronal mechanisms.Cholinergic contributions to the cognitive symptoms of schizophrenia and the viability of cholinergic treatmentsMethamphetamine-like discriminative-stimulus effects of nicotinic agonistsNicotinic acetylcholine receptors in attention circuitry: the role of layer VI neurons of prefrontal cortex.The effects of acute nicotine, chronic nicotine, and withdrawal from chronic nicotine on performance of a cued appetitive response.Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: an overview of preclinical and clinical findings.
P2860
Q24598925-BA00F3C4-A85C-48F6-8A0B-1B77879D3D1DQ24614080-5B63E6AA-1E50-4256-AA78-CC79DC99FB62Q24614793-2EBC62DA-09D2-41C0-AB44-FC961F64E406Q26991451-AD4476AD-A0D4-4BA8-BC79-4EF8F287C67FQ27324628-650D77AD-0A09-45E6-ADE2-16B39DAACD83Q30360018-3D5A31AE-FF41-4D63-8449-D4444D7E4839Q30371220-90C3C7BF-9356-4520-BDF8-935CF2C3A636Q30459624-1FF896A8-AC11-4A1B-A9F6-03F41C51FF90Q30475610-C39174C8-4F50-43D5-B807-BFA03AC9E06CQ30489404-118FE4CE-9A81-4C15-B2B2-2F52F1F9D8A6Q30493072-6D891DF5-4863-4A26-B911-9EF82786BF7BQ30500431-72E4A451-6CE3-409D-A0CA-5E1587E15CC2Q30501338-782677CB-2B35-47B4-BEEB-3950CE138511Q30827614-C8128053-AEC3-4271-BDD7-F2E7A7DFBC87Q33693605-D2BFA8E3-4AA1-49D9-AF1B-85D6ED09598BQ33768017-1892986C-B068-4BA4-8F59-7539C6B7441FQ33830056-6F0313FA-4CE9-47E3-9503-24CE24DEC554Q33898631-BB010E5F-70E3-45CE-BAFC-784B405FBD64Q34355481-69267BF8-AC9E-43C5-B79E-C63D684E8FA2Q34359939-AF45D6ED-A7F0-4B21-9D1C-2B065FF457D8Q34390062-D1408EA9-EF27-4771-9F02-17EABE43A0E3Q34561031-D7BE3C74-F537-4E15-B1C7-02D6ACDF245FQ34661221-6E6ADE4F-31C9-42BC-B22D-0A651AA9530FQ35048154-C490D952-54D3-43BB-8F8B-6E36C1032274Q35652883-64691ADD-753E-4974-819A-AA3FAA2AD8AAQ36238293-738EF38C-6E57-4FBB-B194-59A4D21F4CC2Q36295731-714BEC31-9652-470B-9DBC-17B90C50DA4CQ36652326-72A3A4D7-B7B5-405B-A5A5-97A0BFA25CEFQ36917265-9499C21D-13DC-4E82-B0A2-983634C527CAQ37125488-12FD1784-CAE6-4B15-9DB5-2C297029F1F5Q37127723-513BF55A-EC22-4DB7-B07E-949426081A58Q37254990-F53C5859-C8FA-47B7-9B09-B2F0A12118B9Q37337365-69C656BC-51C3-4FDD-B646-30DCA6A287CBQ37399710-28352BE5-171C-4307-BC31-896B7F6FB59FQ37465460-0FB0369A-5511-4F73-B13D-AB2C3B162EE0Q37576675-D094DD45-F4D0-4EA4-BAE7-CD760A582435Q37603896-CDD48AC3-CECD-45E4-A7FB-E39297F2E85FQ37629127-E4400985-1F6F-4C5B-9913-65D9E5866E6EQ37706033-3AA14C3F-7318-4F70-A222-1ACD6B8280FDQ37826637-83CBC8DC-B766-448C-907B-A57864A601F6
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Attentional effects of nicotinic agonists in rats.
@en
type
label
Attentional effects of nicotinic agonists in rats.
@en
prefLabel
Attentional effects of nicotinic agonists in rats.
@en
P2093
P1433
P1476
Attentional effects of nicotinic agonists in rats.
@en
P2093
Britta Hahn
Christopher G V Sharples
Ian P Stolerman
Mohammed Shoaib
Susan Wonnacott
P304
P356
10.1016/S0028-3908(03)00099-6
P577
2003-06-01T00:00:00Z